CLINICAL EFFECTIVENESS OF PHARMACOTHERAPY AND MORPHOLOGICAL CHANGES IN RENAL TISSUE IN PATIENTS WITH CHRONIC PYELONEPHRITIS
Main Article Content
Abstract
Abstract: Background: Chronic pyelonephritis (CP) is a common inflammatory disease of the urinary tract characterized by progressive interstitial fibrosis, tubular atrophy, and gradual deterioration of renal function. Persistent inflammation may lead to chronic kidney disease and eventual renal insufficiency.
Article Details
References
Foxman B. Epidemiology of urinary tract infections. Nat Rev Urol. 2014.
Nicolle LE. Urinary tract infections. Clin Geriatr Med. 2019.
Johnson JR, Russo TA. Acute and chronic pyelonephritis. N Engl J Med. 2018.
Wagenlehner FME et al. Guidelines on Urological Infections. EAU. 2022.
Campbell-Walsh Urology. 12th Edition. 2021.
Brenner and Rector’s The Kidney. 11th Edition. 2020.
Kumar V., Abbas A., Aster J. Robbins Basic Pathology. 11th Edition. 2023.
Harrison's Principles of Internal Medicine. 21st Edition. 2022.
KDIGO Clinical Practice Guidelines for CKD. 2023.
WHO Global Report on Kidney Diseases. 2023.
European Association of Urology Guidelines. 2024.
National Kidney Foundation Recommendations. 2023.
Alpers CE. Renal Pathology Review. 2021.
Taal MW. Brenner’s Nephrology. 2020.
Oxford Textbook of Nephrology. 2022.